期刊文献+

抗人SOCS3单克隆抗体的制备及其生物学特性鉴定 被引量:3

Preparation and characterization of a monoclonal antibody against human SOCS3
下载PDF
导出
摘要 目的制备高效价的抗人SOCS3单克隆抗体并对其生物学特性进行鉴定。方法以重组GST-SOCS3融合蛋白免疫BALB/c小鼠,取其脾细胞与Sp2/0细胞融合,经多次筛选及克隆化,建立可稳定分泌抗SOCS3单克隆抗体的杂交瘤细胞株。用ELISA及Western blot鉴定单克隆抗体的特性,并测定其效价、Ig亚类及相对亲和力。结果筛选到一株可稳定分泌抗人SOCS3单克隆抗体的杂交瘤细胞株。Western blotting显示在相对分子质量为6.3×104处出现特异性反应带。杂交瘤细胞培养上清效价为1∶640,腹水效价为1∶25600,Ig亚类为IgG2a,相对亲和力达4.84×106L/mol。结论成功制备能特异性识别人SOCS3的单克隆抗体,为进一步研究人体细胞因子信号传导的负反馈调节及SOCS3在微生物感染中的免疫调节作用奠定了基础。 Objective To prepare and characterize the monoclonal antibody (mAb) against human SOCS3. Methods BALB/c mice were immunized with recombinant GST-SOCS3 protein, from which the spleen cells were isolated and fused with Sp2/0 cells. After several rounds of screening and cloning, the hybridoma cell strain secreting anti-SOCS3 mAb was obtained, whose specificity was evaluated using ELISA and Western blotting, and the titer, immunoglobulin subtype and affinity of the mAb were also measured. Results The hybridoma cell strain secreting anti-SOCS3 mAb was identified to belong to IgG2a subtype. The mAb titers in cultural supematant and ascetic fluid were 1:640 and 1:25600, respectively, as determined by ELISA with affinity reaching 4.84×^10^6 L/mol. Conclusion The success in anti-SOCS3 mAb preparation provides the basis for further study of the negative regulation of cytokine signal transduction and the immunoregulation in microorganism infections.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2007年第11期1778-1780,1783,共4页 Journal of Southern Medical University
关键词 SOCS3 单克隆抗体 抗体制备 杂交瘤细胞 SOCS3 monoclonal antibody preparation hybridoma cells
  • 相关文献

参考文献10

  • 1Cooney RN. Suppressors of cytokine signaling (SOCS): inhibitors of the JAK/STAT pathway[J]. Shock, 2002, 17(1): 83-90.
  • 2Yu CR, Mahdi RM, Ebong S, et al. Suppressor of cytokine signaling 3 regulates proliferation and activation of T-helper cells [J ]. J Biol Chem, 2003, 278(32): 29752-9.
  • 3王艺颖,高红亮,张毅.细胞因子发信号阻抑蛋白SOCS3作用机制及其在相关疾病中的研究[J].生命的化学,2005,25(2):147-150. 被引量:3
  • 4Bcatty JD, Barbara BG, William GV. Measurement of monoclonal antibody affinity by non-competitive enzyme immunoassay [J]. Immunol Methods, 1987, 100: 173-9.
  • 5Dey BR, Furlanetto RW, Nissley P. Suppressors of cytokine signaling (SOCS)-3 protein interacts with the insulin-like growth factor-I reccptor[J ]. Biochem Biophys Res Commun, 2000, 278:38-43.
  • 6Jane C, Tan RR. Suppressors of cytokine signaling in health, and disease[J]. Pediatr Nephrol, 2005, 20(5): 567-71.
  • 7Dalpke A, Opper S, Zimmermann S, et al. Suppressors of cytokine signaling (SOCS)-I and SOCS-3 are induced by CpG-DNA and modulate cytokine responses in APCs [J]. J Immunol, 2001, 166 (12): 7082-9.
  • 8Stoiber D, Kovarik P, Colmey S, et al. Lipopolysaccharide induces in macrophages the synthesis of the suppressor of cytokine signaling 3 and suppresses signal transduction in response to the activating factor lFN-gamma[J]. J Immunol, 1999, 163(5): 2640-7.
  • 9Bedato C, Cassatella MA, Kinjyo L, et al. Involvement of suppressor of cytokine signaling-3 as a mediator of the inhibitory effects of IL-10 on lipopolysaccharide-induced macrophage activation [J]. J Immunol, 2002, 168:6404-11.
  • 10Lebel E, Vallieres L, Rivest S. Selective involvement ofinterleukin-6 in the transcriptional activation of the suppressor of cytokine signaling-3 in the brain during systemic immune challenges [J]. Endocrinology, 2000, 141(10): 3749-63.

二级参考文献18

  • 1Krebs DL et al. J Cell Sci, 2000, 113:2813-2819.
  • 2Sasaki A et al. J Biol Chem, 2003, 278(4): 2432-2436.
  • 3De Souza D et al. Biochemistry, 2002, 41(29): 9229-9236.
  • 4Cacalano NA et al. Nat Cell Biol, 2001, 3(5): 460-465.
  • 5Sasaki A et al. J Biol Chem, 2000, 275(38): 29338-29347.
  • 6Roberts AW et al. Proc Natl Acad Sci USA, 2001, 98(16):9324-9329.
  • 7Takahashi Yet al. EMBO J, 2003, 22(3): 372-384.
  • 8He B et al. Clin Lung Cancer, 2004, 5(6): 366-370.
  • 9He B et al. Proc Natl Acad Sci, 2003, 100(24): 14133-14138.
  • 10Brender C et al. Leukemia, 2005, 19(2): 209-213.

共引文献2

同被引文献40

  • 1张韶君,龚凤英,邓洁英,朱惠娟,潘慧,张殿喜,李乃适.锌α_2糖蛋白真核表达载体的构建和体外表达鉴定[J].中国医学科学院学报,2010,32(3):283-288. 被引量:3
  • 2张莉红,徐永健,张珍祥.SOCS在哮喘发病中的作用[J].国外医学(呼吸系统分册),2005,25(9):663-664. 被引量:1
  • 3王念鸿,郭晓蕙.SOCS-3与胰岛素抵抗[J].国外医学(内分泌学分册),2005,25(6):409-411. 被引量:5
  • 4邹大进,吴鸿.腹型肥胖致胰岛素抵抗的机制及治疗展望[J].中国糖尿病杂志,2006,14(4):309-312. 被引量:39
  • 5Wincewicz A,Sulkowska M,Rutkowski R,et al.STAT1 and STAT3as intracellular regulators of vascular remodeling[J].Eur J Intern Med,2007,18(4):267-271.
  • 6Endo TA,Masuhara M,Yokouchi M,et al.A new protein containing an SH2domain that inhibits JAK kinases[J].Nature,1997,387(6636):921-924.
  • 7Krebs DL,Hilton DJ.SOCS:physiological suppressors of cytokine signaling[J].J Cell Sci,2000,113(pt16):2813-2819.
  • 8Kamizono S,Hanada T,Yasukawa H,et al.The SOCS box of SOCS-1accelerates ubiquitin-dependent proteolysis ofTEL-JAK2[J].J Biol Chem,2001,276(14):12530-12538.
  • 9senn JJ,Klover PJ,Nowak IA,et al.Suppressor of cytokine signaling3(SOCS3),a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes[J].J Biol Chem,2003,278(16):13740-13746.
  • 10Chen T,Huang Z,Wang L,et al.MicroRNA-125a-5p partly regulates the inflammatory response,lipid uptake,and ORP9expression in ox-LDL stimulated monocyte/mac-rophages[J].Cardiovasc Res,2009,83(1):131-139.

引证文献3

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部